Kayne Anderson Rudnick Investment Management
ATRC icon

Kayne Anderson Rudnick Investment Management’s AtriCure ATRC Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed -$1K – 570
2020
Q4 		$1K Buy
+10
New +$432 ﹤0.01% 574

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's ATRC Position: Q1 2021 in Review

Kayne Anderson Rudnick Investment Management sold out of AtriCure (ATRC) in Q1 2021, closing a stake of 10 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in ATRC in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 191 funds tracked by Wall St. Rank hold ATRC as of Q1 2021.

  • Kayne Anderson Rudnick Investment Management reported no remaining AtriCure position as of Q1 2021 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 10 AtriCure shares in Q1 2021, an estimated $1K.
  • Kayne Anderson Rudnick Investment Management first reported a position in AtriCure in Q4 2020 and held it in 1 quarter.
  • Kayne Anderson Rudnick Investment Management's AtriCure position peaked at $1K in Q4 2020.
  • 191 funds tracked by Wall St. Rank held AtriCure as of Q1 2021.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2021, filed 17 May 2021.